Document Detail


Neurovascular rescue for embolic stroke following atrial septal defect closure.
MedLine Citation:
PMID:  12216933     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Strokes following cardiac surgery occur in about 5% of patients. Intra-arterial thrombolysis is a good option in such a setting where intravenous thrombolysis is contraindicated, and when in-hospital strokes are detected well within the window for treatment and the chances of complete reperfusion are maximum. On postoperative day 4 after atrial septal defect correction, a 34-year-old woman with paroxysmal atrial fibrillation developed left middle cerebral artery stroke causing severe neurological deficits. Intra-arterial thrombolysis with urokinase led to remarkable recovery.
Authors:
M A Joy; Anand Kumar; K V Hariprasad; Prakash Kamath; K K Haridas
Related Documents :
1414933 - Patterns of myoglobin and mm creatine kinase isoforms release early after intravenous t...
8006283 - Dose finding with a novel recombinant plasminogen activator (bm 06.022) in patients wit...
23481493 - Endoplasmic reticulum stress pathway involvement in local and remote myocardial ischemi...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Indian heart journal     Volume:  54     ISSN:  0019-4832     ISO Abbreviation:  Indian Heart J     Publication Date:    2002 May-Jun
Date Detail:
Created Date:  2002-09-09     Completed Date:  2002-11-08     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0374675     Medline TA:  Indian Heart J     Country:  India    
Other Details:
Languages:  eng     Pagination:  309-11     Citation Subset:  IM    
Affiliation:
Department of Neurology and Cardiology, Amrita Institute of Medical Sciences and Research Centre, Kochi.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cerebral Angiography
Female
Fibrinolytic Agents / therapeutic use
Heart Septal Defects, Atrial / surgery*
Humans
Postoperative Complications / drug therapy*,  etiology
Stroke / drug therapy*,  etiology
Thrombolytic Therapy / methods*
Treatment Outcome
Urokinase-Type Plasminogen Activator / therapeutic use
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.73/Urokinase-Type Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interventional therapy for multiple cardiac defects.
Next Document:  Pathways of allorecognition: implications for transplantation tolerance.